0001567619-18-002984.txt : 20180920
0001567619-18-002984.hdr.sgml : 20180920
20180920193348
ACCESSION NUMBER: 0001567619-18-002984
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180918
FILED AS OF DATE: 20180920
DATE AS OF CHANGE: 20180920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Feener Edward P.
CENTRAL INDEX KEY: 0001691090
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36830
FILM NUMBER: 181080375
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE, BUILDING 200
STREET 2: SUITE 2203
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KalVista Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001348911
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200915291
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 200, STE. 2203
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: (857) 999-0075
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 200, STE. 2203
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Therapeutics, Inc.
DATE OF NAME CHANGE: 20140916
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Biosurgery, Inc
DATE OF NAME CHANGE: 20130102
FORMER COMPANY:
FORMER CONFORMED NAME: Carbylan Biosurgery Inc
DATE OF NAME CHANGE: 20060105
4
1
doc1.xml
FORM 4
X0306
4
2018-09-18
0
0001348911
KalVista Pharmaceuticals, Inc.
KALV
0001691090
Feener Edward P.
C/O KALVISTA PHARMACEUTICALS, INC.
55 CAMBRIDGE PARKWAY, SUITE 901E
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Common Stock
2018-09-18
4
A
0
12500
0
A
110534
D
Common Stock
2018-09-18
4
F
0
2500
17.05
D
108034
D
Employee Stock Option (Right to Buy)
16.08
2018-09-18
4
A
0
52600
0
A
2028-09-17
Common Stock
52600
52600
D
Represents the number of shares vested upon the achievement of certain performance criteria pursuant to a performance based restricted stock units ("PSUs") granted by the Issuer's Compensation Committee in June 2018. No sale or disposition of these shares is contemplated until after the expiration of the applicable lock-up period.
Represents the number of shares of common stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale by the reporting person.
The option vests over a 4 year period: 1/48th on October 18, 2018, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
/s/Benjamin Palleiko, Attorney-in-Fact
2018-09-20